90 likes | 205 Views
Explore the impact of myeloma on dialysis patients' survival rates, age at treatment initiation, and causes of death. Unadjusted survival data for myeloma and non-myeloma patients undergoing dialysis are analyzed, along with risk factors for mortality in Australia and New Zealand from 1963 to 2009.
E N D
CHAPTER 10 CANCER CHAPTER
Table 1: Characteristics of people with and without myeloma treated by dialysis between 1963-2009
Figure 1: Plot of myeloma diagnosis relative to timing of ESKD and dialysis commencement
Figure 2a: Unadjusted survival on dialysis for myeloma versus non myeloma patients
Figure 2b Unadjusted survival on dialysis, stratified by primary renal disease
Table 2: Average age of people starting dialysis through time
Table 3: Cause of death for people on dialysis with and without myeloma in Australia and New Zealand 1963-2009 *
Figure 3: Unadjustedsurvival on dialysis for people with (MM) and without myeloma (non-MM), by age at starting dialysis and stratified by era of treatment *
Table 4: Risk of death for people with myeloma treated with dialysis in Australia and New Zealand 1963-2009